Recent News

• 03.19.2026 - What Is TMS Therapy? A Non-Drug Treatment for Depression
• 03.17.2026 - Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
• 03.03.2026 - Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call

Recent Filings

• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.17.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.17.2026 - EX-99.1 EX-99.1
• 03.17.2026 - 8-K Current report
• 03.17.2026 - S-3 Registration statement under Securities Act of 1933